Form 4 for CAI Caris Life Sciences, Inc.
Accepted 2025-06-23 00:00:00 ET · period of report 2025-06-18 · accession 0001104659-25-061802 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-23 | 2025-06-20 | CAI | Brille Brian J | See Remarks, Dir | P - Purchase | $21.00 | +30.0K | 162.4K | +23% | +$630.0K | |
| 2025-06-23 | 2025-06-18 | CAI | Brille Brian J | See Remarks, Dir | A - Grant | $0.00 | +132.4K | 132.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-20 | P | A | 30,000 | $21.00 | 162,428 | D | — | — | |
| 2 | Common | Common Stock | 2025-06-18 | A | A | 132,428 | $0.00 | 132,428 | D | — | — | (F1) Represents an award of restricted stock units which vest in accordance with the applicable grant agreement. |